Mesenchymal Stem Cell-Conditioned Medium Reduces Disease Severity and Immune Responses in Inflammatory Arthritis
- Submitting institution
-
University of Keele
- Unit of assessment
- 12 - Engineering
- Output identifier
- 420
- Type
- D - Journal article
- DOI
-
10.1038/s41598-017-18144-w
- Title of journal
- Scientific Reports
- Article number
- 18019
- First page
- -
- Volume
- 7
- Issue
- 1
- ISSN
- 2045-2322
- Open access status
- Compliant
- Month of publication
- December
- Year of publication
- 2017
- URL
-
https://www.nature.com/articles/s41598-017-18144-w
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
7
- Research group(s)
-
-
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- This output demonstrated the therapeutic potential of mesenchymal stem cell-conditioned medium for the treatment of inflammatory arthritis. Support was provided via the Dowager Countess Eleanor Peel Trust (AJT.1064.2.MJA (13/05)) and the Orthopaedic Institute Ltd (133). Follow-on funding was obtained from the Robert Jones and Agnes Hunt Orthopaedic Hospital Charity (G08028), a British Society for Immunology summer placement award, and a Keele University PhD studentship. This work led to subsequent publications (Hyland et al, 2020) and conference presentations (TERMIS World Congress, USA, 2015; 2nd Vinmec International Conference ‘Cell and Gene Therapy’, Vietnam, 2018).
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
